
The first International extracellular matrix pharmacology congress
The aim of the ECM2022 congress is to focus on development of new drugs targeting the extracellular matrix and improve our understanding of changes to the extracellular matrix across chronic diseases.
Alterations to the extracellular matrix are a common denominator in most chronic diseases. It is not merely a consequence of the diseases but an active driver. Creating a forum for experts to discuss, share and learn from other disease fields will be essential for patients and future drug development. A forum will help increase the understanding of the extracellular matrix across chronic diseases and accelerate the development of drugs targeting the extracellular matrix.
ECM2022 will bring together experts to discuss the extracellular matrix across diseases, and you are invited to join us in Copenhagen June 23-25 in 2022.
Read welcome message from congress Chair, Prof. Morten Karsdal, below.
Read the messageProgram at-a-glance
Below is a snapshot of what to expect each day! View or download the tentative program for more details on sessions and ECM experts.
Thursday, June 23
9:15 – 10:45 CET
Opening session and keynote 1
11:00 – 12:30 CET
Session 1: The essential components of the ECM
14:15 – 15:45 CET
Session 2: The importance of ECM in cancer
16:30 – 17:15 CET
Panel Debate 1: The history of the ECM and what it means to me
17:30 – 18:30 CET
Midsummer networking session
Friday, June 24
9:15 – 10:45 CET
Session 3: The importance of ECM in lung disease
11:15 – 12:45 CET
Session 4: Cardiorenal axis and the ECM
14:30 – 16:00 CET
Session 5: Pharmacological targets of the ECM
16:15 – 17:15 CET
Keynote 2
18:30 – 24:00 CET
Congress dinner
Saturday, June 25
8:30 – 10:00 CET
Session 6: ECM Signaling
11:00 – 12:00 CET
Panel Debate 2: Should we treat the ECM or the cells?
13:15 – 15:15 CET
Session 7: Tissue destruction in inflammatory diseases
15:30 – 16:30 CET
Close of congress, Award ceremony and Keynote speak

Keynotes and Speakers
Meet our international ECM experts, including:
- Valerie Weaver, University of California, USA
- Raghu Kalluri, University of Texas MD Anderson Cancer Center, USA
- Mina Bissell, Lawrence Berkeley National Laboratory, USA
- Richard O. Hynes, Massachusetts Institute of Technology, USA
- Detlef Schuppan, Johannes Gutenberg Universität Mainz, Germany
Sponsors
ECM2022 is grateful for the support of our sponsors. Visit the sponsor page for more information.
